Literature DB >> 2441612

Microlesion formation in myocardial cells by high-intensity electric field stimulation.

J L Jones, R E Jones, G Balasky.   

Abstract

Arrhythmias, S-T segment changes, immediate refibrillation, and other signs of dysfunction are often observed after clinical and experimental transthoracic defibrillation. In vitro studies suggested that shock-induced dysfunction is induced by sarcolemmal dielectric breakdown accompanied by ionic exchanges through transient, shock-induced microlesions in the sarcolemma. To test this hypothesis, cultured chick embryo myocardial cells were shocked in media containing fluorescein isothiocyanate-labeled dextrans (FITC-dextrans) ranging in molecular mass from 4 to 70 kDa, using electric field stimulation 5 ms in duration and ranging in intensity from 0 to 200 V/cm. Results showed that the percentage of cells incorporating 4- to 20-kDa dextrans increased in a dose-dependent manner. The 4- and 10-kDa dextrans were incorporated beginning at intensities of 50-100 V/cm. Dextran incorporation corresponded with shock intensities which produced a shock-induced arrest of spontaneous contraction lasting 1 min. The 20-kDa dextrans were incorporated following 150- and 200-V/cm shocks. Shocks of these intensities also produced a transient postshock contracture. Larger dextrans (40 and 70 kDa) were not incorporated. These results suggest the formation of transient sarcolemmal microlesions having a diameter of 45-60 A during high-intensity electric field stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441612     DOI: 10.1152/ajpheart.1987.253.2.H480

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  Modeling electroporation in a single cell. I. Effects Of field strength and rest potential.

Authors:  K A DeBruin; W Krassowska
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

2.  Asymmetry in membrane responses to electric shocks: insights from bidomain simulations.

Authors:  Takashi Ashihara; Natalia A Trayanova
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

3.  Electroporation-induced inward current in voltage-clamped guinea pig ventricular myocytes.

Authors:  Oksana Dyachok; Pavel Zhabyeyev; Terence F McDonald
Journal:  J Membr Biol       Date:  2010-11-21       Impact factor: 1.843

4.  Validating defibrillation simulation in a human-shaped phantom.

Authors:  Jess D Tate; Thomas A Pilcher; Kedar K Aras; Brett M Burton; Rob S MacLeod
Journal:  Heart Rhythm       Date:  2019-11-23       Impact factor: 6.343

5.  Cell-attached patch clamp study of the electropermeabilization of amphibian cardiac cells.

Authors:  R J O'Neill; L Tung
Journal:  Biophys J       Date:  1991-05       Impact factor: 4.033

6.  Atria are more susceptible to electroporation than ventricles: implications for atrial stunning, shock-induced arrhythmia and defibrillation failure.

Authors:  Vadim V Fedorov; Geran Kostecki; Matt Hemphill; Igor R Efimov
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

7.  Electric field-induced functional reductions in the K+ channels mainly resulted from supramembrane potential-mediated electroconformational changes.

Authors:  W Chen; Y Han; Y Chen; D Astumian
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

8.  Low K+-induced hyperpolarizations trigger transient depolarizations and action potentials in rabbit ventricular myocytes.

Authors:  M Akuzawa-Tateyama; M Tateyama; R Ochi
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

9.  Cardiac myocyte excitation by ultrashort high-field pulses.

Authors:  Sufen Wang; Jiexiao Chen; Meng-Tse Chen; P Thomas Vernier; Martin A Gundersen; Miguel Valderrábano
Journal:  Biophys J       Date:  2009-02-18       Impact factor: 4.033

10.  Electric countershock and cold stress effects on liver and adrenal gland.

Authors:  Marcelo Ferreira; Luiz Carlos de Abreu; Vitor E Valenti; Adriano Meneghini; Neif Murad; Celso Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.